Annual D&A
$12.63M$535.00K-4.07%
Summary
- Current Value
- As of today, XERS annual D&A is $12.63M, down -4.07% on
- Historical Performance
- XERS annual D&A is up +571.90% over the past 3 years, and up +1071.15% over the past 5 years
- All-Time High Comparison
- XERS annual D&A is currently -4.07% below its historical high of $13.16M set on
- 3-Year Low Comparison
- XERS annual D&A is at its 3-year low
- Sector Comparison
- XERS annual D&A is higher than 73.80% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $12.63M | -4.1% | +571.9% | +1071.2% | +10000.0% | |
| Quarterly D&A | $3.19M | +2.1% | +3.8% | +732.6% | +8292.1% | |
| TTM D&A | $12.63M | -1.0% | +25.5% | +801.4% | +10000.0% | |
| Price | $7.21 | +115.2% | +586.7% | +24.3% | – | |
| Annual SG&A | $163.48M | +11.9% | +30.0% | +159.2% | +3926.6% | |
| Annual Total Expenses | $236.72M | +13.8% | +43.7% | +89.2% | +1554.7% | |
| Annual Operating Expenses | $199.88M | +11.5% | +32.0% | +61.9% | +1298.0% | |
| Annual Revenue | $203.07M | +23.9% | +309.5% | +7360.3% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $13.16M | -4.1% | |
| 5Y | $13.16M | -4.1% | |
| All | $13.16M | -4.1% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $12.63M | at low | |
| 5Y | $1.47M | N/A | +760.6% |
| All | $116.00K | >+9999.0% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $12.63M | -4.1% | |
| $13.16M | +3.9% | |
| $12.67M | +574.2% | |
| $1.88M | +28.1% | |
| $1.47M | +36.1% |
| Year | Value | Change |
|---|---|---|
| $1.08M | +236.9% | |
| $320.00K | +42.2% | |
| $225.00K | +94.0% | |
| $116.00K | - |
FAQ
What is the current annual D&A of XERS?
As of today, XERS annual D&A is $12.63M
What is 1-year change in XERS annual D&A?
XERS annual D&A is down -4.07% year-over-year
What is 3-year change in XERS annual D&A?
XERS annual D&A is up +571.90% over the past 3 years
How far is XERS annual D&A from its all-time high?
XERS annual D&A is currently -4.07% below its historical high of $13.16M set on December 31, 2023
How does XERS annual D&A rank versus sector peers?
XERS annual D&A is higher than 73.80% of companies in Healthcare sector
When is XERS next annual earnings release?
The next annual earnings release for XERS is on
Quarterly D&A
$3.19M$25.00K+0.79%
Summary
- Current Value
- As of today, XERS quarterly D&A is $3.19M, up +0.79% on
- Historical Performance
- XERS quarterly D&A is up +2.08% year-over-year, and up +3.84% over the past 3 years
- All-Time High Comparison
- XERS quarterly D&A is currently -8.96% below its historical high of $3.50M set on
- 3-Year Low Comparison
- XERS quarterly D&A is +2.08% above its 3-year low of $3.12M reached on
- Sector Comparison
- XERS quarterly D&A is higher than 71.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $3.19M | +0.8% | +2.1% | +3.8% | +732.6% | |
| Annual D&A | $12.63M | – | -4.1% | +571.9% | +1071.2% | |
| TTM D&A | $12.63M | +0.5% | -1.0% | +25.5% | +801.4% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| Quarterly SG&A | $46.46M | +4.7% | +3.3% | +34.7% | +181.8% | |
| Quarterly Total Expenses | $73.76M | +0.4% | +5.4% | +43.1% | +189.8% | |
| Quarterly Operating Expenses | $53.94M | +2.9% | +6.1% | +33.3% | +179.8% | |
| Quarterly Revenue | $74.38M | +4.0% | +37.1% | +150.2% | +687.3% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.19M | at high | |
| 3Y | $3.50M | N/A | -9.0% |
| 5Y | $3.50M | -9.0% | |
| All | $3.50M | -9.0% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.13M | N/A | +1.8% |
| 3Y | $3.12M | +2.1% | |
| 5Y | $320.00K | +896.6% | |
| All | $5,000.00 | >+9999.0% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of XERS?
As of today, XERS quarterly D&A is $3.19M
What is XERS quarterly D&A most recent change?
XERS quarterly D&A was up +0.79% on September 30, 2025
What is 1-year change in XERS quarterly D&A?
XERS quarterly D&A is up +2.08% year-over-year
How far is XERS quarterly D&A from its all-time high?
XERS quarterly D&A is currently -8.96% below its historical high of $3.50M set on December 31, 2022
How does XERS quarterly D&A rank versus sector peers?
XERS quarterly D&A is higher than 71.79% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
TTM D&A
$12.63M$65.00K+0.52%
Summary
- Current Value
- As of today, XERS TTM D&A is $12.63M, up +0.52% on
- Historical Performance
- XERS TTM D&A is down -0.96% year-over-year, and up +25.49% over the past 3 years
- All-Time High Comparison
- XERS TTM D&A is currently -5.78% below its historical high of $13.40M set on
- 3-Year Low Comparison
- XERS TTM D&A is +0.60% above its 3-year low of $12.55M reached on
- Sector Comparison
- XERS TTM D&A is higher than 71.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $12.63M | +0.5% | -1.0% | +25.5% | +801.4% | |
| Annual D&A | $12.63M | – | -4.1% | +571.9% | +1071.2% | |
| Quarterly D&A | $3.19M | +0.8% | +2.1% | +3.8% | +732.6% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| TTM SG&A | -$2.72B | -1666.6% | -1789.3% | -1825.2% | -3659.2% | |
| TTM Revenue | $266.14M | +8.2% | +42.0% | +170.1% | +1659.3% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $12.63M | at high | |
| 3Y | $13.40M | -5.8% | |
| 5Y | $13.40M | -5.8% | |
| All | $13.40M | -5.8% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $12.55M | +0.6% | |
| 3Y | $12.55M | +0.6% | |
| 5Y | $1.43M | +785.6% | |
| All | $38.00K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of XERS?
As of today, XERS TTM D&A is $12.63M
What is XERS TTM D&A most recent change?
XERS TTM D&A was up +0.52% on September 30, 2025
What is 1-year change in XERS TTM D&A?
XERS TTM D&A is down -0.96% year-over-year
How far is XERS TTM D&A from its all-time high?
XERS TTM D&A is currently -5.78% below its historical high of $13.40M set on September 30, 2023
How does XERS TTM D&A rank versus sector peers?
XERS TTM D&A is higher than 71.79% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers